Sapience Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics to address difficult to treat oncology indications, announced that it has raised $22.5 million in a Series A financing.
VidRovr, an innovative video management and processing platform developed by PhD students in Columbia Engineering’s Digital and Multimedia Lab, has been named among the Publicis90, a select group of start-ups that will receive funding and a year of guidance from executive mentors at Publicis Groupe.
Columbia Engineering Professor Steven K. Feiner and Ajoy Fernandes MS’16 have developed a method of combating virtual reality (VR) sickness that can be applied to consumer head-worn VR displays, such as the Oculus Rift, HTC Vive, Sony PlayStation VR, and Google Cardboard.
Scientists from the Center for Radiological Research at Columbia University Medical Center have shown that a narrow wavelength of ultraviolet (UV) light safely killed drug-resistant MRSA bacteria in mice, demonstrating a potentially safe and cost-effective way to reduce surgical site infections.
A new study reports on the results of a randomized clinical trial that looked at whether the antidepressant citalopram would enhance complicated grief treatment psychotherapy, and if citalopram would be efficacious without it.